Literature DB >> 31735315

When Pulmonary Hypertension Complicates Heart Failure.

Alberto-Maria Marra1, Nicola Benjamin2, Antonio Cittadini3, Eduardo Bossone4, Ekkehard Grünig5.   

Abstract

Pulmonary hypertension (PH) often complicates chronic left-sided heart failure, with a remarkable impact on quality of life, exercise capacity, and survival. PH in chronic left-sided heart failure (PH-LHD) is not only caused by backward transmission of pressures but also involves impairment of atrial function, inflammation, and vasoconstriction. Once the left atrium loses its reservoir capacity, usually pulmonary vascular resistances increase. Right atrial dilation commonly represents the first sign of PH-LHD, before right ventricle dilatation and systolic dysfunction develop, leading to right heart insufficiency, and ultimately, right heart failure.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chronic heart failure; Heart failure with preserved ejection fraction; Pulmonary hypertension; Right ventricle

Mesh:

Year:  2020        PMID: 31735315     DOI: 10.1016/j.hfc.2019.08.004

Source DB:  PubMed          Journal:  Heart Fail Clin        ISSN: 1551-7136            Impact factor:   3.179


  3 in total

1.  The comparative effects of sacubitril/valsartan versus enalapril on pulmonary hypertension due to heart failure with a reduced ejection fraction.

Authors:  Ying Zhao; Li-Guo Tian; Li-Xin Zhang; Tao Ma; Liang Di; Yan-Bo Wang; Xin-Shun Gu; Dan-Dan Wang; Shang Gao; Haiyan Wang
Journal:  Pulm Circ       Date:  2022-07-01       Impact factor: 2.886

2.  Plasma MIR-212-3p as a biomarker for acute right heart failure with pulmonary artery hypertension.

Authors:  Yue Yang; Renhua Li; Yanan Cao; Sisi Dai; Sumei Luo; Qulian Guo; E Wang
Journal:  Ann Transl Med       Date:  2020-12

3.  Apolipoprotein A1 is associated with pulmonary vascular resistance and adverse clinical outcomes in patients with pulmonary hypertension secondary to heart failure.

Authors:  Wande Yu; Xie Dujiang; Wang Yi; Ding Guanwen; Zhang Mengyu; Pan Chang; Zhang Aikai; Zhang Juan; Zhu Linlin; Zhang Hang
Journal:  Pulm Circ       Date:  2022-07-01       Impact factor: 2.886

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.